Hoey Timothy's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Feb 21, 2024
- Accession no.
- 0000950170-24-018222
- Filed
- Feb 21, 2024
- Trade date
- Feb 20, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $35.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoey TimothyCIK 0001553333 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | Common Stock | SSaleDisposed | −6,369 | $5.31 | −$33,819.39 | 236,346 | Direct | |
| Feb 20, 2024 | Common Stock | SSaleDisposed | −200 | $6.17 | −$1,234 | 236,146 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.